149 related articles for article (PubMed ID: 36876759)
21. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
Zafar R; Schrader LJ; Cheville JC; Schoolmeester JK; Roden AC; Aubry MC; Yi ES; Raghunathan A; Herrera-Hernandez L; Thompson RH; Boorjian SA; Leibovich BC; Keeney GL; Jimenez RE; Gupta S
Hum Pathol; 2022 Oct; 128():31-47. PubMed ID: 35809685
[TBL] [Abstract][Full Text] [Related]
22. Histological and immunohistochemical characteristics and
Fujishima F; Konosu-Fukaya S; Nabeshima K; McNamara KM; Sakamoto K; Sakurada J; Sasano H; Nakamura Y
Indian J Pathol Microbiol; 2021; 64(2):277-281. PubMed ID: 33851620
[TBL] [Abstract][Full Text] [Related]
23. Mesothelioma in situ of the peritoneum: report of three cases and review of the literature.
Symes E; Tjota M; Cody B; Kindler H; Mitchell O; Witmer H; Turaga K; Mueller J; Krausz T; Husain AN; Li H
Histopathology; 2024 Feb; 84(3):492-506. PubMed ID: 38084880
[TBL] [Abstract][Full Text] [Related]
24. Well-differentiated papillary mesothelioma.
Butnor KJ; Sporn TA; Hammar SP; Roggli VL
Am J Surg Pathol; 2001 Oct; 25(10):1304-9. PubMed ID: 11688466
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of localized pleural mesothelioma.
Hung YP; Dong F; Dubuc AM; Dal Cin P; Bueno R; Chirieac LR
Mod Pathol; 2020 Feb; 33(2):271-280. PubMed ID: 31371807
[TBL] [Abstract][Full Text] [Related]
26. New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?
Churg A; Sheffield BS; Galateau-Salle F
Arch Pathol Lab Med; 2016 Apr; 140(4):318-21. PubMed ID: 26288396
[TBL] [Abstract][Full Text] [Related]
27. 5-hmC loss is another useful tool in addition to BAP1 and MTAP immunostains to distinguish diffuse malignant peritoneal mesothelioma from reactive mesothelial hyperplasia in peritoneal cytology cell-blocks and biopsies.
Alsugair Z; Kepenekian V; Fenouil T; Glehen O; Villeneuve L; Isaac S; Hommell-Fontaine J; Benzerdjeb N
Virchows Arch; 2022 Jul; 481(1):23-29. PubMed ID: 35575935
[TBL] [Abstract][Full Text] [Related]
28. Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma.
Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Iwasaki A; Nabeshima K
Mod Pathol; 2020 Feb; 33(2):235-244. PubMed ID: 31231129
[TBL] [Abstract][Full Text] [Related]
29. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
[TBL] [Abstract][Full Text] [Related]
30. The separation of benign and malignant mesothelial proliferations.
Churg A; Colby TV; Cagle P; Corson J; Gibbs AR; Gilks B; Grimes M; Hammar S; Roggli V; Travis WD
Am J Surg Pathol; 2000 Sep; 24(9):1183-200. PubMed ID: 10976692
[TBL] [Abstract][Full Text] [Related]
31. SOX6 Expression Is Sensitive for Peritoneal Epithelioid Malignant Mesothelioma, But Not Specific in the Differential Diagnosis With Tubo-ovarian Serous Neoplasia.
Chapel DB; Hirsch MS
Am J Surg Pathol; 2022 Feb; 46(2):213-219. PubMed ID: 34411029
[TBL] [Abstract][Full Text] [Related]
32. Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers.
Trupiano JK; Geisinger KR; Willingham MC; Manders P; Zbieranski N; Case D; Levine EA
Mod Pathol; 2004 Apr; 17(4):476-81. PubMed ID: 14976533
[TBL] [Abstract][Full Text] [Related]
33. Pediatric, Adolescent and Young Adult (AYA) Peritoneal and Pleural Mesothelioma: A National Cancer Database Review.
Nofi CP; Roberts BK; Rich BS; Glick RD
J Pediatr Surg; 2024 Jun; 59(6):1113-1120. PubMed ID: 38418273
[TBL] [Abstract][Full Text] [Related]
34. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.
Dragon J; Thompson J; MacPherson M; Shukla A
J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056
[TBL] [Abstract][Full Text] [Related]
35. Solid papillary mesothelial tumor.
Churg A; Le Stang N; Dacic S; Pissaloux D; Begueret H; Dartigues P; Giusiano-Courcambeck S; Sequeiros R; Pairon JC; Tirode F; Galateau-Sallé F
Mod Pathol; 2022 Jan; 35(1):69-76. PubMed ID: 34480081
[TBL] [Abstract][Full Text] [Related]
36. The cytological features of effusions with mesothelioma in situ: A report of 9 cases.
Michael CW; Bedrossian CCWM; Sadri N; Klebe S
Diagn Cytopathol; 2023 Jun; 51(6):374-388. PubMed ID: 36942732
[TBL] [Abstract][Full Text] [Related]
37. A Case of Solitary Well-Differentiated Papillary Mesothelioma with Invasive Foci in the Pleura.
Shimizu S; Yoon HE; Ito N; Tsuji T; Funakoshi Y; Utsumi T; Sakaguchi M; Tsujimura T; Kasai T; Hiroshima K; Matsumura A
Pathol Int; 2017 Jan; 67(1):45-49. PubMed ID: 27886416
[TBL] [Abstract][Full Text] [Related]
38. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
Kinoshita Y; Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Hiroshima K; Oda Y; Nabeshima K
Cancer Cytopathol; 2018 Jan; 126(1):54-63. PubMed ID: 29053210
[TBL] [Abstract][Full Text] [Related]
39. Malignant peritoneal mesothelioma.
Chun CP; Song LX; Zhang HP; Guo DD; Xu GX; Li Y; Xin X; Cao J; Li F
Am J Med Sci; 2023 Jan; 365(1):99-103. PubMed ID: 35940275
[TBL] [Abstract][Full Text] [Related]
40. Mesothelioma of Uncertain Malignant Potential (MUMP) of the Tunica Vaginalis: Proposal for Reclassification as "Complex Mesothelial Tumor of the Tunica Vaginalis".
Ding CC; Van Roo J; Kryvenko ON; Ye H; McKenney JK; Epstein JI
Am J Surg Pathol; 2024 Apr; 48(4):387-394. PubMed ID: 38270560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
